April Wang Armstrong MD MPH
Chief of Dermatology at UCLA, Professor of Medicine
Join to View Full Profile
911 Broxton Ave3rd floorLos Angeles, CA 90024
Phone+1 800-872-2273
Fax+1 323-442-5953
Dr. Armstrong is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008- Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
Harvard Medical SchoolClass of 2004
Harvard School of Public HealthClinical Effectiveness Program- Harvard School of Public HealthM.P.H.
Certifications & Licensure
CA State Medical License 2008 - 2028
CO State Medical License 2013 - 2017
MA State Medical License 2004 - 2008
American Board of Dermatology Dermatology
National Board of Medical ExaminersDiplomate
Awards, Honors, & Recognition
- Presidential Citation for Contributions to Psoriasis Research and Clinical Care American Academy of Dermatology, 2016
- Young Dermatologist International Achievement Award International League of Dermatological Societies (ILDS)., 2015
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2015
Clinical Trials
- Comparison Of Video-based Versus Written Patient Education on Sunscreen Start of enrollment: 2009 Jan 01
- Comparison of Video-Based Versus Written Patient Education on Melanoma Start of enrollment: 2009 Jan 01
- Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 1 citationsLebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis.Jonathan I Silverberg, Thomas Bieber, Kilian Eyerich, April W Armstrong, Brian J Nickoloff
The Journal of Dermatological Treatment. 2026-12-01 - Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ...Linda Stein Gold, April W Armstrong, Jennifer Soung, Ronald B Vender, Álvaro González Cantero
The British Journal of Dermatology. 2026-07-03 - GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic Arthritis/Psoriasis Care and Resource Limitations.Elaine J Ma, Rose Boit, Ying Ying Leung, Shikha Singla, Daniel Fernández-Ávila
The Journal of Rheumatology. 2026-07-01
Lectures
- Controversies and Difficult Questions Concerning Biologic TherapeuticsAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
- New Concepts and Emerging Therapies in Metabolic Disorders and Vascular Disease 2012UC Davis Health System, Monterey, California - 10/6/2012
Other
- Pathologic characteristics of melanomaArmstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-characteristics-of-melanoma
UpToDate, Wolters Kluwer Health - 2013-01-27 - Pathologic evaluation of regional lymph nodes in melanomaArmstrong AW, Mihm MC, Liu V
http://www.uptodate.com/contents/pathologic-evaluation-of-regional-lymph-nodes-in-melanoma
UpToDate, Wolters Kluwer Health - 2012-08-09 - Treatment selection for moderate to severe plaque psoriasis in special populationsArmstrong AW
http://www.uptodate.com/contents/treatment-selection-for-moderate-to-severe-plaque-psoriasis-in-spec
UpToDate, Wolters Kluwer Health - 2013-02-14
Press Mentions
Curbing Costs & Burden: Comparing Phototherapy Options for Patients with PsoriasisFebruary 12th, 2025- FDA Approves First Once-Daily Oral Plaque Psoriasis DrugSeptember 18th, 2022
- How to Spot the Difference Between Chronic and Acute InflammationAugust 30th, 2021
Grant Support
- Assessment of Treatment Satisfaction in PsoriasisUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
- Team-Based Connected Health to Improve Access and Outcomes in Atopic DermatitisUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2025
Committees
- Chair, Sub-Committee On Teledermatology Outreach, American Telemedicine Association 2009 - 2011
- Member, National Psoriasis Foundation Strategic Planning Committee
Research History
- Researcher1. investigating epidemiology of comorbid conditions associated with inflammatory skin diseases such as psoriasis 2. evaluating the safe use of systemic medications for chronic inflammatory skin diseases 3. improving health care quality and effectiveness using tech-enabled healthcare delivery models
Professional Memberships
- Fellow
- Clinical Guidelines Committee
- Chair, Workforce Committee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
